Possible side effects include: Nausea, diarrhea, vomiting, constipation, mild to moderate abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, belching, hypoglycemia, flatulence, gastroenteritis, loss of lean muscle mass and gastroesophageal reflux disease
This is not recommended unless directed by your healthcare provider
At week 52, more participants in the semaglutide, liraglutide groups respectively than in the placebo group achieved weight reductions of 3% (43.6%, 28.6% vs
2021 Feb
Similarly, the elevated amylase level most likely reflected systemic inflammation rather than acute pancreatitis, since no pancreatic abnormalities were identified on imaging